MEA Rare diseases in the Middle East and Africa are no longer an afterthought. As regulatory frameworks mature and governments demand deeper partnership, access, science and local commitment are being redefined. In this interview, Sherif Basha explains how Versalya Pharma is building a rare diseases platform designed for long-term impact, translating…
Morocco Women’s health specialist Versalya enjoyed a resurgent 2022 in Morocco under the leadership of Sofia Lahlou. She explains some of the key trends in the Moroccan women’s health space, how the company is supporting the healthcare transformation underway in the country, and her approach to talent attraction and retention. …
Global The top 10 most-read interviews on PharmaBoardroom in 2020 represents the broad geographic scope we have had in the past year. From Mexico to Morocco and Romania to Riyadh, these local insights help give a more well-rounded global picture of our industry today. 1. Bill Sibold, Executive VP, Sanofi…
Morocco Sofia Lahlou, country manager for women’s and children’s health specialist Versalya in the Moroccan market, discusses the company’s formation, its therapeutic priorities, and the opportunities that exist for women in leadership in Morocco. Today, we are the only laboratory in Morocco exclusively dedicated to women’s and children’s well-being, supporting…
See our Cookie Privacy Policy Here
